In this study, 83.64% of the DCIS recurrences demonstrated high/low GOLPH3 expression in carcinoma cells, while only 10.91% of the DCIS without recurrence showed high/low GOLPH3 expression. This evidence concerns the gene GOLPH3 and ductal breast carcinoma in situ.